- Home
- CBNK vs PROK Comparison
CBNK vs PROK Comparison
Compare CBNK & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBNK | PROK |
|---|---|---|
| Founded | 1974 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.4M | 417.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CBNK | PROK |
|---|---|---|
| Price | $28.49 | $2.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $34.00 | $6.25 |
| AVG Volume (30 Days) | 49.2K | ★ 1.4M |
| Earning Date | 01-26-2026 | 11-10-2025 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | ★ 26.24 | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $222,152,000.00 | $744,000.00 |
| Revenue This Year | $44.59 | $918.66 |
| Revenue Next Year | $6.44 | N/A |
| P/E Ratio | $9.67 | ★ N/A |
| Revenue Growth | ★ 40.71 | N/A |
| 52 Week Low | $24.69 | $0.46 |
| 52 Week High | $36.40 | $7.13 |
Technical Indicators
Market Signals| Indicator | CBNK | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 44.95 |
| Support Level | $26.50 | $2.04 |
| Resistance Level | $28.96 | $2.25 |
| Average True Range (ATR) | 0.82 | 0.19 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 80.66 | 45.90 |
Price Performance
Historical ComparisonAbout CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.